On Tuesday, U.S. stocks showed mixed results. The Dow Jones Industrial Average closed down by nearly 0.8%, finishing at 39,112.16. The S&P 500 rose by almost 0.4% to end the regular session at 5,469.30, while the Nasdaq climbed nearly 1.3% to close at 17,717.65.
These are the top stocks that gained the attention of retail traders and investors throughout the day:
Rivian Automotive Inc RIVN
Rivian shares surged 8.63% to close at $11.96 after reports of Volkswagen’s plan to invest $5 billion into the company as part of an electric vehicle joint venture. The German automaker is set to invest $1 billion immediately and pump an additional $4 billion over time. The joint venture will focus on developing next-generation battery-powered vehicles.
Lucid Group Inc LCID
Lucid Group shares traded lower by 2.34% to close at $2.50 on Tuesday. The company announced the appointment of Nick Twork as head of Global Communications, who will oversee Lucid's global communications team and report directly to Lucid CEO Peter Rawlinson.
Micron Technology Inc MU
Micron Technology shares rose by 1.52% to close at $141.12. Rosenblatt analyst Hans Mosesmann maintained Micron as a Buy with a $225 price target, expecting the company to deliver a beat-and-raise as it enters one of the most significant memory cycles in history.
Novo Nordisk NVO
Novo Nordisk shares moved higher by 3.25% to close at $146.91 following China's approval of Novo's weight loss drug, Wegovy. China, the second most populated country, is estimated to have the world's highest number of overweight individuals. Read more here.
Tesla Inc TSLA
Tesla shares increased by 2.61% to close at $187.35. Emil Michael, former chief business officer at Uber Technologies, recently expressed skepticism about the financial feasibility of robotaxis, citing the high cost of production.
Photo by WHYFRAME on Shutterstock
Prepare for the day’s trading with top premarket movers and news by Benzinga.
Read Next: NVDA, AFRM, CCL, ALNY, TSLA: Top 5 Trending Stocks Today
This story was generated using Benzinga Neuro and edited by Shivdeep Dhaliwal
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.